Skip to content
healthcare.dev

Aleve Caplets

NDC 85237-1832, NAPROXEN SODIUM, tablet, from Select Consumer Group.

Product NDC
85237-1832
Status
Listed
Labeler
Select Consumer Group
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA020204
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85237-1832 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
85237-1832-1852371832011 POUCH in 1 BLISTER PACK (85237-1832-1) / 1 TABLET in 1 POUCH (85237-1832-0)
85237-1832-2852371832022 POUCH in 1 BLISTER PACK (85237-1832-2) / 1 TABLET in 1 POUCH
85237-1832-48523718320425 POUCH in 1 BOX, UNIT-DOSE (85237-1832-4) / 1 TABLET in 1 POUCH
85237-1832-68523718320650 POUCH in 1 BOX, UNIT-DOSE (85237-1832-6) / 1 TABLET in 1 POUCH
85237-1832-7852371832073 POUCH in 1 BLISTER PACK (85237-1832-7) / 1 TABLET in 1 POUCH (85237-1832-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85237-1832 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85237-1832 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85237-1832. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.